Tentech (CEO Han Dong-ok), a medical device manufacturer, announced that it has successfully signed supply contracts worth a total of USD 11.5 million with key distributors from Thailand, the UAE, and Russia at the 2025 KIMES (Korea International Medical & Hospital Equipment Show), accelerating its global market expansion.

At the 2025 KIMES, Tentech further strengthened its presence in the Chinese market by signing an additional supply contract worth KRW 60 billion with Feizer, a Chinese medical aesthetics distribution company. Through this contract, the company aims to expand the global market share of its flagship lifting device, 10THERMA, and skin regeneration device, 10REVIV.

In the Thai market, Tentech signed an exclusive supply contract for 10THERMAwith Aesthetics By Ampex, amounting to USD 10 million. With the growing demand for high-quality lifting solutions in Southeast Asia, the company expects this contract to significantly strengthen the presence of 10THERMAin Thailand.

In the UAE, Tentech successfully secured an exclusive supply contract worth USD 500,000 with Sense Skin Beauty & Personal Care Equipment Trading L.L.C. The popularity of non-invasive lifting procedures is rising in the Middle East, and Tentech anticipates that the innovative technology of 10THERMAwill generate substantial interest in the local market.

For the Russian market, Tentech signed an exclusive supply contract with Stellar Medfor the microneedle RF device 10REVIV, with a contract value of USD 1 million. Given the strong interest in skin regeneration and anti-aging solutions in Russia, 10REVIVis expected to attract significant attention from local medical and aesthetic professionals.

Regarding the KRW 60 billion supply contract with Feizer, Tentech revealed plans to supply 1,500 units of 10THERMAover the next three years. This deal follows the company’s previous contract with Paragonin 2023, further solidifying Tentech’s position in the Chinese market.

A Tentech representative stated, "Through these meaningful contracts at the 2025 KIMES, we have once again proven Tentech’s technological excellence and product competitiveness on the global stage. We will continue to achieve steady success in the Chinese market and establish ourselves as a leading company in the global medical aesthetics industry."

Tentech is continuously expanding its global presence through cutting-edge medical aesthetic technology and differentiated product competitiveness. By strengthening cooperation with key medical institutions and partners worldwide, the company provides tailored solutions optimized for regional market characteristics. Moving forward, Tentech plans to lead innovation in the global medical aesthetics industry through continuous R&D investments and strategic partnerships.